Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Algernon’s business model is based on drug re-purposing, finding new uses for know drugs





 

Bullboard - Investor Discussion Forum Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc > A neo-Nazi Pez Dispenser Of Hate Speech - Lands "Investment
View:
Post by C10H12N2 on Jan 01, 2023 7:42am

A neo-Nazi Pez Dispenser Of Hate Speech - Lands "Investment

Advice" Article @ Algernon Pharmaceuticals

Christopher Temple algernonpharmaceuticals.com... Christopher Temple is a KNOWN Conman & Federally Convicted Felon - All the way down to a local Firefighter. "F. Hall Machon, a disabled and partially blind former firefighter in Massachussetts, said he first heard about Temple through his Spotlight articles. He would spend hours talking to Temple, he says, about their shared love of hockey. "He wrote terrific Christmas letters and talked about his children," Machon said. Machon says he tracked Temple's stock picks for four years while working as a firefighter. The returns were so good that Machon ultimately took $12,000 from his retirement account to invest. When he asked for it back, Machon alleges, Temple demurred. "He's smart," Machon told the Report, "but he's just a crook."" Neo-Nazi Pez Dispenser

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

Connect with C.AGN


CEO Clips: DMT Clinical Trial

CEO Q&A Interview with Chris Moreau

Investor Presentation

Download the latest Investor Presentaion

Algernon Highlights: The Watchlist

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Investment Opportunity

The Algernon Value Proposition



  • Advancing new drug treatments for billion dollar global disease markets.
  • Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.
  • Conducting multiple phase II clinical trials.
  • Highly capital efficient business model.
  • Experienced management team & globally recognized medical advisory board.

Facebook